ASCO publishes survivorship care plan template

Share on facebook
Share on twitter
Share on linkedin
Share on email
Share on print

THE AMERICAN SOCIETY OF CLINICAL ONCOLOGY published a revised template for survivorship care plans.

Plans should contain information about treatment the patient received, their need for future checkups and cancer tests, the potential long-term late effects of the treatment they received, and ideas for ways survivors can improve their health, according to ASCO.

The new template, updating a previous version the society developed nearly a decade ago, was published in the Journal of Oncology Practice as part of a statement on the importance of complete survivorship care plans. The template is also part of ASCO’s Cancer Survivorship Compendium, and is available through ASCO’s patient information website.

YOU MAY BE INTERESTED IN

In April 2025, announcements from the two most influential biomedical agencies in the US, the FDA and the NIH, declared that both will seek to reduce and minimize animal-based testing and experimentation. These declarations sparked joy in some circles, and deep concern in others that was reflected in a 28% fall in the share price of Charles River Labs (NYSE: NYSE:CRL). 
Over the past three decades, cancer genetics has transformed precision oncology. Germline testing has advanced from single-gene Sanger sequencing to parallel sequencing of hundreds of genes, while tumor (somatic) testing has expanded with the rise of targeted therapies based on point mutations, copy number changes and other alterations. 

Never miss an issue!

Get alerts for our award-winning coverage in your inbox.

Login